1Hendrich J,Van Minh AT,Heblich F,et al.Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin.Proc Natl Acad Sci U S A,2008,105:3628-3633.
2Lynch BA,Lambeng N,Nocka K,et al.The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.Proc Nail Acad Sci U S A,2004,101:9861-9866.
3Madsen KK,White HS,Schousboe A,et al.Neuronal and nonneuronal GABA transporters as targets for antiepileptic drugs.Pharmacol Ther,2010,125:394-401.
4Inoue Y,Ohtsuka Y,Oguni H,et al.Stiripentol open study in Japanese patients with Dravet syndrome.Epilepsia,2009,50:2362-2368.
5Luszczki JJ.Third-generation antiepileptic drugs:mechanisms of action,pharmacokinetics and interactions.Pharmacol Rep,2009,61:197-216.
6Huang Z,Walker MC,Shah MM.Loss of dendritic HCN1 subunits enhances cortical excitability and epileptogenesis.J Neuresci,2009,29:10979-10988.
7Reddy DS,Rogawski MA.Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model.Epilepsy Res,2010,89:254-260.
8Scharfman HE.Brain-derived neurotrophic factor and epilepsy--a missing link? Epilepsy Curr,2005,5:83-88.
10Reddy DS,Rogawski MA.Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model[J].Epilepsy Research,2010,23 (2):121-123.
